On July 7th, J&J once again led the way in the new and social media world within the pharma industry, by launching their branded YouTube Channel — the Johnson & Johnson Health Channel. While it’s not the first pharma company to make use of YouTube (e.g. the Novartis’ FluFlix campaign), it is certainly the first pharma company – to my knowledge — to brand it’s own channel.
Here’s a brief synopsis from their blog about the launch of the YouTube Channel :
Last week - after months of work — the Johnson & Johnson health channel was launched on You Tube. On it, I’m uploading videos produced by Dr. Nancy Snyderman when she worked at Johnson & Johnson. Each two-to-three minute video addresses various health-related topics such as teenage obesity, nutrition, aging, heart disease, cancer and mental illness. Though we may make products that can be used to treat some of the conditions Dr. Snyderman talks about, no brand names are mentioned. After all, this is about health information and advice -as provided by Dr. Snyderman.
On the blog post, there’s additional commentary by Rob Halper, who shares a sentiment that I can really relate to, in terms of making scientific and medical knowledge more accessible (not just within silos and “walled gardens“) and how pharma can contribute to society in that respect…
What struck me as I went through Dr. Snyderman’s videos in preparation for putting them online was just how much stuff we have. Health care companies like Johnson & Johnson have a wealth of information and knowledge that they have acquired over the years - in part because it is through this knowledge and understanding that we can develop new products, treatments and services that can help in the delivery of healthcare. But all too often, much of this knowledge isn’t shared with people, physicians or patients for a variety of reasons (such as regulatory oversight, confidentiality and other business concerns…)
Yet as I observe the ongoing dialog about health-related matters online, I can’t help but think that companies like Johnson & Johnson can be more involved in this conversation - even if it is simply to share some basic information that have been gathered over the years.
In my opinion, J&J is probably one of the most progressive of all the major pharma and healthcare players, having forged the way with JNJBTW.com and CNTR411.com blogs, and now the YouTube Health Channel. I certainly applaud and respect them for taking the chance to move forward with these new and social media opportunities, as the governing agencies for the industry continue to try and figure out exactly how to regulate this rapidly evolving technology space.
As mentioned in a write up by PharmaExec…
“We’ve seen a proliferation on YouTube of health content and health videos,” explained Neha Parekh, senior marketing manager of health at Google. “There has been an embrace from the healthcare community to put up videos and have a platform to create dialogue.”
Just like all other forms of media on the Internet, there are no pharma regulations pertaining to videos for online platforms such as YouTube. “It’s up to pharma companies to decide how to best utilize the Web,” Parekh said. “There is concern, but pharma is trying to figure out what they can do, because they know that the consumers are [on the Web].”
…Video sites, such as YouTube and Vimeo, offer pharma companies a place to show off media assets that are currently collecting dust. While companies could host the videos on their own branded Web sites, YouTube drives massive traffic with more than 80 million users.
And unlike blogs or forums, pharma companies can take full control of online video. They don’t have to worry about negative comments being left after a post (YouTube comments can be turned off), and they can brand and edit the content as they see fit, tailoring the programming for a particular audience. Videos can also be removed as needed.
While I agree with the most of what was said, I have to say that the last paragraph just doesn’t quite add up. It’s true that you can take control of online video and control the commenting function for YouTube, but I believe most social software (such as blogs) allow you to manage commenting as well. And, just as with online video, any content that is hosted by a professional organization (especially in this industry) really should be reviewed and edited before posting and you can certainly target it to particular audiences or remove a post completely if you need to.
In addition, while Neha Parekh from Google suggests that there are “no pharma regulations pertaining to videos online”, it is probably only prudent and makes common sense for pharma companies NOT to go beyond what they are traditionally held to by the FDA for promotional materials and DTC ads.
However, I believe the more important issue that isn’t discussed in the PharmaExec article, is the fact that, while you can take control of all these functions for most social media (and you will probably be required to do so to some extent by your legal and regulatory departments), how much would you really want to? After all, part of the whole success of Web 2.0 technologies in driving traffic via viral distribution/marketing is partly because of the ability to comment, share, contribute and everything else that Web 2.0 does so well.
Overall, I am just glad that J&J took the first step to start a YouTube channel and can only hope that it will lead the way for more health care companies and pharmaceuticals to open up their closed silos and share the wealth of knowledge and health education that often gets locked away behind the legal and regulatory walls. Congratulations J&J!
Recent Comments